Celanese Corporation Common Stock (CE) Financial Statements
Historical financial data — 40 statements covering FY2016–FY2025
Celanese is one of the world's largest producers of acetic acid and its downstream derivative chemicals, which are used in various end markets, including coatings and adhesives. The company is also...
Celanese Corporation Common Stock's revenue decreased 7.2% year over year, from $10.28B to $9.54B.
Net income increased 23.5% over the same period, from $-1.52B to $-1.17B.
Over the 9-year period from FY2016 to FY2025, revenue grew by 77% in total.
Total debt remained relatively stable at $12.60B.
The debt-to-equity ratio stands at 3.11, indicating a high leverage profile.
Operating cash flow grew 18.6% to $1.15B.
Celanese Corporation Common Stock maintains a negative net profit margin of -12.2%.
Recent Financial Statements
| Period | Revenue | Net Income | Gross Profit | EBIT | Op. Cash Flow | Total Assets | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| Q2 FY2023 | $5.65B+98.0% | $311.0M | $1.32B | $586.0M | $666.0M | $25.65B | $14.40B | $5.62B |
| Q3 FY2023 | $8.37B+48.2% | $1.26B | $1.99B | $1.43B | $1.07B | $25.54B | $13.70B | $6.49B |
| Q1 FY2024 | $2.61B-68.8% | $121.0M | $554.0M | $210.0M | $101.0M | $26.03B | $13.46B | $7.07B |
| Q2 FY2024 | $5.26B+101.5% | $276.0M | $1.20B | $460.0M | $393.0M | $25.81B | $13.04B | $7.17B |
| Q1 FY2025 | $2.39B-54.6% | $-21.0M | $476.0M | $168.0M | $37.0M | $23.20B | $12.78B | $5.19B |
| Q2 FY2025 | $4.92B+106.0% | $178.0M | $1.01B | $401.0M | $447.0M | $23.71B | $12.94B | $5.28B |
| Q3 FY2025 | $7.34B+49.2% | $-1.18B | $1.53B | $-879.0M | $894.0M | $22.17B | $12.85B | $3.95B |
| Q1 FY2026 | $2.34B-68.2% | $44.0M | $468.0M | $214.0M | $76.0M | $21.73B | $12.55B | $4.06B |